1. 1) Aboyans V, Ricco JB, Bartelink MEL, et al: 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 39: 763–816, 2018
2. 2) Pourier VE, de Borst GJ: Technical options for treatment of in-stent restenosis after carotid artery stenting. J Vasc Surg 64: 1486–1496, 2016
3. 3) 小林 望,眞野加奈子:プラスグレルが有効であったステント内血栓症の2症例.脳血管内治療 2: 6–10, 2017
4. 4) Saito S, Isshiki T, Kimura T, et al: Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study. Circ J 78: 1684–1692, 2014
5. 5) Jongen LM, Hendrikse J, Waaijer A, et al: Frequency and consequences of early in-stent lesions after carotid artery stent placement. J Vasc Interv Radiol 20: 573–579, 2009